Silvant Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-14,332
| Closed | -$805K | – | 307 |
|
2024
Q4 | $805K | Sell |
14,332
-106
| -0.7% | -$5.96K | 0.03% | 151 |
|
2024
Q3 | $984K | Sell |
14,438
-408
| -3% | -$27.8K | 0.04% | 144 |
|
2024
Q2 | $627K | Sell |
14,846
-216
| -1% | -$9.13K | 0.03% | 149 |
|
2024
Q1 | $1.04M | Buy |
15,062
+943
| +7% | +$65.1K | 0.05% | 149 |
|
2023
Q4 | $1.04M | Sell |
14,119
-2,181
| -13% | -$161K | 0.06% | 140 |
|
2023
Q3 | $1.11M | Sell |
16,300
-783
| -5% | -$53.4K | 0.07% | 143 |
|
2023
Q2 | $1.6M | Buy |
17,083
+1,123
| +7% | +$105K | 0.09% | 124 |
|
2023
Q1 | $1.08M | Sell |
15,960
-318
| -2% | -$21.6K | 0.07% | 130 |
|
2022
Q4 | $806K | Buy |
16,278
+270
| +2% | +$13.4K | 0.06% | 135 |
|
2022
Q3 | $520K | Sell |
16,008
-96
| -0.6% | -$3.12K | 0.04% | 148 |
|
2022
Q2 | $635K | Buy |
16,104
+26
| +0.2% | +$1.03K | 0.15% | 94 |
|
2022
Q1 | $1.12M | Sell |
16,078
-209
| -1% | -$14.6K | 0.21% | 83 |
|
2021
Q4 | $1.27M | Sell |
16,287
-765
| -4% | -$59.6K | 0.22% | 84 |
|
2021
Q3 | $1.63M | Sell |
17,052
-3,409
| -17% | -$325K | 0.29% | 76 |
|
2021
Q2 | $2.54M | Sell |
20,461
-370
| -2% | -$46K | 0.4% | 65 |
|
2021
Q1 | $2.75M | Sell |
20,831
-640
| -3% | -$84.3K | 0.47% | 58 |
|
2020
Q4 | $2.85M | Sell |
21,471
-429
| -2% | -$56.8K | 0.49% | 54 |
|
2020
Q3 | $2.23M | Sell |
21,900
-5,796
| -21% | -$591K | 0.42% | 63 |
|
2020
Q2 | $2.41M | Sell |
27,696
-1,851
| -6% | -$161K | 0.43% | 60 |
|
2020
Q1 | $1.71M | Sell |
29,547
-591
| -2% | -$34.3K | 0.37% | 73 |
|
2019
Q4 | $2.79M | Sell |
30,138
-365
| -1% | -$33.8K | 0.51% | 55 |
|
2019
Q3 | $2.76M | Sell |
30,503
-4,121
| -12% | -$372K | 0.54% | 55 |
|
2019
Q2 | $4.09M | Buy |
34,624
+11,241
| +48% | +$1.33M | 0.73% | 36 |
|
2019
Q1 | $2.03M | Buy |
+23,383
| New | +$2.03M | 0.36% | 76 |
|